SEARCH

SEARCH BY CITATION

References

  • Aghajanian, G.K. (1978). Feedback regulation of central mono-aminergic neurons: Evidence from single cell recording studies. In Essays in Neurochemistry and Neuropharmacology. ed. Youdim, M.B.H., Lovenberg, W., Sharman, D.F., Lagnado, J.R. pp. 232. New York: J. Wiley & Sons.
  • Aghajanian, G.K., Sprouse, J.S., Sheldon, P. & Rasmussen, K. (1990). Electrophysiology of the central serotonin system: Receptor subtypes and transducer mechanisms. Ann. NY. Acad. Sci., 600, 93103.
  • Akaoka, H., Charlety, P., Saunier, M., Buda, M. & Chouvet, G. (1992). Inhibition of nigral dopamine neurons by systemic and local apomorphine: Possible contribution of dendritic auto-receptors. Neuroscience, 49, 879891.
  • Anderson, C.D., Pasquier, D.A., Forbes, W.B. & Morgane, P.J. (1977). Locus coeruleus to dorsal raphe input examined by electrophysiological and morphological methods. Brain. Res. Bull., 2, 209221.
  • Aston-Jones, G., Shipley, M.T., Chouvet, G., Ennis, M., Van Bockstaele, E.J., Pieribone, V.A., Shiekhattar, R., Akaoka, H., Drolet, G., Astier, B., Charlety, P., Valentino, R.J. & Williams, J.T. (1991a). Afferent regulation of locus coeruleus neurons: Anatomy, physiology and pharmacology. Prog. Brain Res., 88, 4775.
  • Aston-Jones, G., Akaoka, H., Charlety, P. & Chouvet, G. (1991b). Serotonin selectively attenuates glutamate-evoked activation of noradrenergic locus coeruleus neurons. J. Neurosci., 11, 760769.
  • Baraban, J.M. & Aghajanian, G.K. (1980). Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology, 19, 355363.
  • Baraban, J.M. & Aghajanian, G.K. (1981). Noradrenergic innervation of serotoninergic neurons in the dorsal raphe: Demonstration by electron microscopic autoradiography. Brain Res., 204, 111.
  • Baxter, G., Kennet, G., Blaney, F. & Blackburn, T. (1995). 5-HT2 receptor subtypes: a family re-united. Trends Pharmacol. Sci., 16, 105110.
  • Blandina, P., Goldfarb, J., Walcott, J. & Green, J.P. (1991). Serotonergic modulation of the release of endogenous norepi-nephrine from rat hypothalamus. J. Pharmacol. Exp. Ther., 256, 341347.
  • Blier, P. & De Montigny, C. (1987). Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: Electrophysiological studies in the rat brain. Synapse, 1, 470480.
  • Bobker, D.H. & Williams, J.T. (1989). Serotonin agonists inhibit synaptic potentials in the rat locus coeruleus in vitro via 5-HT1A and 5-HT1B receptors. J. Pharmacol. Exp. Ther., 250, 3743.
  • Bosker, F.J., De Winter, T.Y.C.E., Klompmakers, A.A. & Westenberg, H.G.M. (1996). Flesinoxan dose-dependently reduces extracellular 5-hydroxytryptamine (5-HT) in rat median raphe and dorsal hippocampus through activation of 5-HT1A receptors. J. Neurochem. 66, 25462555.
  • Cedarbaum, J.M. & Aghajanian, G.K. (1978). Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique. J. Comp. Neurol., 178, 116.
  • Chaput, Y. & De Montigny, C. (1988). Effects of the 5-HT1 receptor antagonist BMY 7378 on the 5-HT neurotransmission: Electrophysiological studies in the rat central nervous system. J. Pharmacol. Exp. Ther., 246, 359370.
  • Chiang, C. & Aston-Jones, G. (1993). A 5-hydroxytryptamine2 agonist augments γ-aminobutyric acid and excitatory amino acid inputs to noradrenergic locus coeruleus neurons. Neuroscience, 54, 409420.
  • Clement, H.-W., Gemsa, D. & Weseman, W. (1992). Serotonin-norepinephrine interactions: A voltametric study on the effect of serotonin receptor stimulation followed in the nucleus raphe dorsalis and the locus coeruleus of the rat. J. Neural Transm., 88, 1123.
  • Cox, R., Meller, E. & Waszcsak, B.L. (1993). Electrophysiological evidence for a large receptor reserve for inhibition of dorsal raphe neuronal firing by 5-HT1A agonists. Synapse, 14, 297304.
  • Cravem R., Grahame-Smith, D. & Newberry, N. (1994). WAY 100635 and GR127935: Effects on 5-hydroxytryptamine-contain-ing neurones. Eur. J. Pharmacol., 271, R1R3.
  • Crespi, F., Buda, M., Mcrae-Degueurce, A. & Pujol, J.F. (1980). Alteration in tyrosine hydroxylase activity in the LC after administration of P-chlorophenylalanine. Brain Res., 19, 501509.
  • Davidson, C. & Stamford, A.S. (1995). Evidence that 5-hydroxytryptamine release in the dorsal raphe nucleus is controlled by 5-HT1A, 5-HT1B and 5-HT1D autoreceptors. Br. J. Pharmacol., 114, 11071109.
  • Done, C.J.G. & Sharp, T. (1992). Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo. Br. J. Pharmacol., 107, 240245.
  • Engberg, G. (1992). Citalopram and 8-OH-DPAT attenuate nicotine-induced excitation of central noradrenaline neurons. J. Neural Transm., 89, 149154.
  • Fiorella, D., Rabin, R.A. & Winter, J.C. (1995). The role of the 5-HT2a and 5-HT2c receptors in the stimulus effects of hallucinogic drugs I: Antagonist correlation analysis. Psychopharmacology, 121, 347356.
  • Fischette, C.T., Nock, B. & Renner, K. (1987). Effects of 5,7-DHT on serotonin1 and serotonin2 receptors throughout the central nervous system using quantitative autoradiography. Brain Res., 421, 263279.
  • Fletcher, A., Bill, D.J., Cliffe, I.A., Forster, E.A., Jones, D. & Reilly, Y. (1994). A pharmacological profile of WAY 100635, a potent and selective 5-HT1A receptor antagonist. Br. J. Pharmacol., 112, 91P.
  • Fletcher, A., Forster, E.A., Brown, G., Cliffe, I.A., Hartley, J.E., Jones, D.E., Mclenachan, A., Stanhope, K.J., Critchley, D.J.P., Childs, K.J., Middlefell, V.C., Lanfu-Mey, L., Corradeti, R., Laporte, A.-M., Gozlan, H., Hamon, M & Dourish, C.T. (1996). Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav. Brain. Res., 73, 337353.
  • Fornal, C.A., Metzler, C.W., Veasey, S.C., Mccreary, A.C., Dourish, C.T. & Jacobs, B.L. (1994). Single-unit recordings from freely-moving animals provide evidence that WAY 100635, but not WAY 100135, blocks the action of endogenous serotonin at the 5-HT autoreceptor. Br. J. Pharmacol., 112, 92P.
  • Fuxe, K., Agnati, L. & Everitt, B. (1975). Effects of metergoline on central monamine neurons. Evidence for a selective blockade of central 5-HT receptors. Neurosci. Lett., 1, 283290.
  • Gartside, S.E., Umbers, V., Hajos, M. & Sharp, T. (1995). Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol., 115, 10641070.
  • Goetz, A.S., King, H.K., Ward, S.D.C., True, T.A., Rimele, T.J. & Saussy, D.L. (1995). BMY 7378 is a selective antagonist of the D subtype of α1-adrenoceptors. Eur. J. Pharmacol., 272, R5R6.
  • Golzan, H., Thibault, S., Laporte, A.-M., Lima, L. & Hamon, M. (1995). The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain. Eur. J. Pharmacol. (Mol. Pharmacol.), 288, 173186.
  • Gorea, E. & Adrien, J. (1988). Serotonergic regulation of noradrenergic coerulean neurons: electrophysiological evidence for the involvement of 5-HT2 receptors. Eur. J. Pharmacol., 154, 285291.
  • Griebel, G. (1995). 5-Hydroxytryptamine-interacting drugs in animals models of anxiety disorders: More than 30 years of research. Pharmacol. Ther., 65, 319395.
  • Gurling, J., Ashworth-Preece, M.A., Dourish, C.T. & Rou-Tledge, C. (1994). Effects of acute and chronic treatment with the selective 5-HT1A receptor antagonist WAY 100635 on hippocampal 5-HT release in vivo. Br. J. Pharmacol., 112, 299P.
  • Haddjeri, N., Blier, P. & De Montigny, C. (1996). Effect of the α2-adrenoceptor antagonist mirtazapine on the 5-hydroxytrypta-mine system in the rat brain. J. Pharmacol. Exp. Ther., 277, 861871.
  • Hjorth, S., Bengston, H.J., Milano, S., Lundberg, J.F. & Sharp, T. (1995). Studies on the role of 5-HT1A autoreceptors and α1-adrenoceptors in the inhibition of 5-HT release -I. BMY 7378 and prazosin. Neuropharmacology, 34, 615620.
  • Hjorth, S. & Milano, S. (1995). Further studies on the role of 5-HT1A autoreceptors in the effect of 5-HT reuptake blockade on extracellular 5-HT levels in the rat brain. Soc. Neurosci. Abst., 21, 539.3.
  • Hoyer, D., Clarke, D.E., Fozard, J.R., Hartig, P.R., Martin, G.R., Mylecharane, E.J., Saxena, P.R. & Humphrey, P.P.A. (1994). VII. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46, 157203.
  • Jones, B.E. & Yang, T.-Z. (1985). The efferent projections from reticular formation and locus coeruleus studied by anterograde and retrograde axonal transport in the rat. J. Comp. Neurol., 242, 5692.
  • Kandel, E.R. & Spencer, W.A. (1961). Electrophysiology of hippocampal neurons. II. After potentials and repetitive firing. J. Neurophysiol, 24, 243259.
  • Khawaja, X., Evans, N., Reilly, Y., Ennis, C. & Minchin, M.C.W. (1994). Characterisation of the binding of [3H]WAY 100635, a novel 5-hydroxytryptamine1A receptor antagonist, to the rat. J. Neurochem., 64, 27162726.
  • Kawahara, F., Saito, H. & Katsuki, H. (1994). Inhibition by 5-HT7 receptor stimulation of GABAA receptor-activated current in cultured rat suprachiasmatic neurones. J. Physiol., 478.1 6773.
  • LÉGer, L. & Descarries, L. (1978). Serotonin nerve terminals in the locus coeruleus of the adult rat: A autoradiographic study. Brain Res., 145, 113.
  • Leysen, J.E., Gommeren, W., Van Gompel, P., Wynants, J., Janssen, P.F.M. & Laduron, P.M. (1985). Receptor-binding properties in vitro and in vivo of ritanserin. A very potent and long acting serotonin-S2 antagonist. Mol. Pharmacol., 27, 600611.
  • Leyson, J.E., Geerts, R., Gommeren, W., Verwimp, M. & Van Compel, P. (1982). Regional distribution of serotonin-2 receptor binding sites in the brain and effects of neuronal lesion. Arch. Int. Pharmacodyn. Ther., 256, 301305.
  • Loizou, L.A. (1969). Projections of the nucleus locus coeruleus in the albino rat. Brain Res., 15, 563569.
  • Lovenberg, T.W., Baron, B.M., De Lecea, L., Miller, J.D., Prosser, R.A., Rea, M.A., Foye, P.E., Racke, M., Slone, A.L., Siegel, B.W., Danielson, P.E., Sutcliffe, J.G. & Erlander, M. G. (1993). A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rythms. Neuron, 11, 449458.
  • Luppi, P.-H., Aston-Jones, G., Akaoka, H., Chouvet, G. & Jouvet, M. (1995). Afferent projections to rat locus coeruleus demonstrated by retrograde and anterograde tracing with cholera-toxin B subunit and Phaseolus vulgar is leucoagglutinin. Neuroscience, 65, 119160.
  • Maeda, T., Kojima, Y., Arai, R., Fujimiya, M., Kimura, H., Kitahama, K. & Geffard, M. (1991). Monoaminergic interaction in the central nervous system: A morphological analysis in the locus coeruleus of the rat. Comp. Biochem. Physiol., 98C, 193202.
  • Marwaha, J. & Aghajanian, G.K. (1982). Relative potencies of alpha-1 and alpha-2 antagonists in the locus coeruleus, dorsal raphe and lateral geniculate nuclei: An electrophysiological study. J. Pharmacol. Exp. Ther., 222, 287293.
  • Matsumato, M., Yioshioka, M., Togashi/, H., Tochihara, M., Ikeda, T. & Saito, H. (1995). Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in vivo microdialys. J. Pharmacol. Exp. Ther., 272, 10441051.
  • Mcrea-Degueurce, A., Berod, A., Mermet, A., Keller, A., Chouvet, G., Joh, T. & Pujol, J.F. (1982). Alteration in tyrosine hydroxylase activity elicited by raphe nuclei lesions in the rat locus coeruleus: evidence for the involvement of serotonin afferents. Brain Res., 235, 285301.
  • Mongeau, R., Blier, P. & De Montigny, C. (1994). Activation of 5-HT3 receptors enhances the electrically evoked release of [3H]noradrenaline in rat brain limbic structures. Eur. J. Pharmacol., 256, 269279.
  • Mundey, M.K., Fletcher, A. & Marsden, C.A. (1994). Effect of the putative 5-HT1A antagonist WAY 100635 on 5-HT neuronal firing in the guinea-pig dorsal raphe nucleus. Br. J. Pharmacol., 112, 93P.
  • Mundey, M.K., Fletcher, A., Marsden, C.A. & Fone, K.C.F. (1995). Effect of iontophoretic application of the 5-HT1A antagonist WAY 100635 on neuronal firing in the guinea-pig dorsal raphe nucleus. Br. J. Pharmacol., 115, 84P.
  • Newberry, N.R., Watkins, C.J., Sprosen, T.S., Blackburn, T.P., Grahame-Smith, D.G. & Leslie, R.A. (1993). BRL 46470 potently antagonizes neural responses activated by 5-HT3 receptors. Neuropharmacology, 32, 729735.
  • Paxinos, G. & Watson, C. (1982). The Rat Brain in Stereotaxic Coordinates. Sydney: Academic Press.
  • Pickel, V.M., Joh, T.H. & Reis, D.J. (1977). A serotonergic innervation of noradrenergic neurons in nucleus locus coeruleus: demonstration by immunocytochemical localization of transmitter specific enzymes tyrosine hydroxylase. Brain Res., 131, 197214.
  • Pieribone, V.A., Van Bockstaele, E.J., Shipley, M.T. & Aston-Jones, G. (1989). Serotonergic innervation of rat locus coeruleus derives from non-raphe brain areas. Soc. Neurosci. Abst., 15, 168.17.
  • Piñeyro, G., Blier, P., Dennis, T. & De Montigny, C. (1994). Desensitization of the neuronal 5-HT carrier following its long-term blockade. J. Neurosci., 14, 30363047.
  • Pompeiano, M., Palacios, J.M. & Mengod, G. (1994). Distribution of the serotonin 5-HT2 receptor family mRNAs: Comparison between 5-HT2A and 5-HT2C receptors. Mol. Brain Res., 23, 163178.
  • Ranck, J.B. (1975). Behavioural correlates and firing repertoires of neurons in the dorsal hippocampal formation and septum of unrestrained rats. In The Hippocampus. ed. Isaacson, R.L. & Pribram, K.H. pp. 207244. New York: Plenum.
  • Rasmussen, K. & Aghajanian, G.K. (1986). Effect of hallucinogens on spontaneous locus coeruleus unit activity in the rat: Reversal by selective 5-HT2 antagonists. Brain Res., 385, 395400.
  • Reader, T.A., Briere, R., Grondin, L. & Ferron, A. (1986). Effects of p-chlorophenylalanine on cortical monamines and on electrical activity of noradrenergic neurons. Neurochem. Res., 11, 10251035.
  • Romero, L., Bel, N., Artigas, F., De Montigny, C. & Blier, P. (1996). Effect of pindolol on the function of pre- and postsynaptic 5-HT1a receptors: In vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology, 15, 349360.
  • Ruat, M., Traiffort, E., Leurs, R., Tardivel-Lacombe, J., Diaz, J., Arrang, J.-M. & Schwartz, J.-C. (1993). Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc. Natl. Acad. Sci. U.S.A., 90, 85478551.
  • Sanghera, M.K., Coke, J.A., Williams, H.L. & Mcmillen, B.A. (1990). Ipsapirone and 1-(2-pyrimidinyl)-piperazine increase rat locus coeruleus noradrenergic activity. Brain Res. Bull., 24, 1722.
  • Sanghera, M.K., Mcmillen, B.A. & German, D.C. (1983). Buspirone, a non-benzodiazepine anxiolytic increases locus coeruleus noradrenergic neuronal activity. Eur. J. Pharmacol., 86, 107110.
  • Segal, M. (1979). Serotonergic innervation of the locus coeruleus from the dorsal raphe and its action on the responses to noxious stimuli. J. Physiol., 286, 401415.
  • Shen, Y., Monsma, Jr, F.J., Metcalf, M.A., Jose, P.A., Hamblin, M.W. & Sibley, D.R. (1993). Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J. Biol. Chem., 268, 1820018204.
  • Skingle, M., Scopes, D.I.C., Fenuik, W., Connor, H.E., Carter, M.C., Clitherow, J.W. & Tyers, M.B. (1993). GR127935: a potent orally active 5-HT1D receptor antagonist. Br. J. Pharmacol., 110, 9P.
  • Stockmeier, C.A. & Kellar, K.J. (1986). In vivo regulation of the serotonin-2 receptor in rat brain. Life Sci., 38, 117127.
  • Svensson, T.H., Bunney, B.S. & Aghajanian, G.K. (1975). Inhibition of both NA and 5-HT neurons in brain by the α-adrenergic agonist clonidine. Brain Res., 92, 291306.
  • Vertes, R.P. & Kocsis, B. (1994). Projections of the dorsal raphe nucleus to brainstem: PHA-L analysis in the rat. J. Comp. Neurol., 340, 1126.
  • Wright, D.E., Seroogy, K.B., Lundgren, K.H., Davis, B.M. & Jennes, L. (1995). Comparative localization of serotonin1A,1C and 2 receptor subtype mRNAs in rat brain. J. Comp. Neurol., 351, 357373.
  • Yoshioka, M., Matsumoto, M., Togashi, H., Smith, C.B. & Saito (1992). α2-Adrenoceptor modulation of 5-HT biosynthesis in the rat brain. Neurosci. Lett., 139, 5356.
  • Zgombick, J.M., Adham, M., Bard, J.A. Vaysse, P.J.-J., Wein-Shank, R.L. & Branchek, T.A. (1995). Pharmacological characterization of the recombinant human 5-HT7 receptor subtype coupled to adenylate cyclase stimulation in a clonal cell line. Soc. Neurosci. Abst., 21, 537.2.